Physiology Flashcards
What is the most abundant platelet integrin
αIIbβ3
Where are integrins and glycoproteins mainly localized in the platelet membrane
Lipid rafts
Describe the 3 phases of platelet activation
- Initiation:
- Vascular injury -> exposure of subendothelial collagen and vWF
- Shear stress increases binding affinity of vWF for GP1bα receptor
- Plasma vWF gets immobilized on collagen and captures platelets
- Binding of vWF and platelet GP1bα leads to tethering and rolling of platelets then adhesion and formation of platelet monolayer
- Binding of platelets to collagen and vWF triggers platelet activation - Extension:
- Platelet activation leads to shape change, formation of procoagulant membrane, integrin activation
- Local accumulation of thrombin and secretion of thromboxane A2 and ADP activate nearby platelets
- Agonists trigger inside-out signaling (eg. binding of fibrinogen to αIIbβ3 -> activates integrins -> conformation change to high-affinity state - Stabilization:
- Adhesion of platelet integrins to fibrinogen -> outside-in signaling
- Platelet integrins migrate to complexes linked to actin/myosin filament -> contraction strengthening platelet-to-platelet interactions
- Activators stay trapped in this tight platelet aggregation -> local procoagulant microenvironment
- Clot retracts when fibrin gets deposited
What cells contribute to secondary hemostasis
Platelets, leukocytes, fibroblasts + microparticles
What coagulation factors / proteins are vitamin K dependent and why
- Clotting factors II, VII, IX, X, protein C, protein S
- Vitamin K allows the action of the carboxylase in charge of γ-carboxylation of the glutamic acid of these factors / proteins in the liver. This allows them to bind to calcium, which then enables them to interact with phosphatidylserine on cell membranes
What membrane change is required for activation of secondary hemostasis
Disruption of membrane symmetry with exposure of phosphatidylserine (negatively charged) on the surface thanks to the action of scramblase
Draw the coagulation cascade (traditional model)
See picture
Described the phases of the cell-based model of coagulation
- Initiation:
- FVII is converted to FVIIa in the blood (without stimulus)
- Vascular injury -> exposure of tissue-factor bound fibroblasts to FVIIa
- Complex FVIIa-TF activates small amounts of FIX and FX
- FXa activates FV -> FXa-FVa complex = prothrombinase complex
- FXa-FVa complex activates small amounts of FII (prothrombin) -> FIIa - Amplification
- Activated platelets have procoagulant membrane surfaces and release partially activated FV
- FIIa maximizes platelet aggregation and activation
- FIIa activates FXI, FV, and FVIII
*Small amounts of thrombin formed - Propagation:
P for P –> platelets come to the area
- Formation of FIXa-FVIIIa (tenase) and FXa-FVa (prothrombinase) complexes on activated platelets
- FXIa bound to platelets generates more FIXa
- FIXa-FVIIIa complex facilitates generation of FXa -> more FXa-FVa complex formation -> formation of FIIa (thrombin)
- Thrombin cleaves fibrinogen into fibrin monomers
- Fibrin monomers polymerize to form a fibrin clot
- FXIII gets activated by FIIa
- FXIIIa causes crosslinking of fibrin monomers to stabilize fibrin clot
* Lots of thrombin formed - Termination:
- Tissue factor pathway inhibitor (TFPI) is secreted by endothelium and inhibits FVIIa-TF bound to FXa
- Antithrombin (AT) produced by the liver inhibits thrombin formation by forming complexes with FIIa, FIXa, FXa, FXIa, FXIIa (facilitated by heparin and heparan sulfate)
- Protein C is activated by thrombin bound to thrombomodulin (expressed on endothelial cells). Protein C bound with protein S lyse FVa and FVIIIa
What platelet conformation change triggered by their activation is crucial for the rest of the coagulation process
Externalization of phosphatidylserine on the membrane surface
What complex leads to the activation of prothrombin into thrombin
Prothrombinase complex = FXa-FVa
What factor leads to crosslinking of thrombin? What activates it?
FXIIIa, activated by thrombin FIIa
What is the initial reaction and last reaction of intrinsic, extrinsic, and common pathways of coagulation
- Intrinsic pathway: starts by FXII -> FXIIa, ends with FIXa and FVIIIa activating FX
- Extrinsic pathway: FVIIa forms complex with TF, FVIIa-TF leads to activation of FX
- Common pathway: starts with FXa-FVa activating FII to FIIa and ends with crosslinking of fibrin
(FX is considered as part of common pathway)
What are the actions of thrombin? Which ones are pro-clot and which ones are anti-clot?
- Platelet activation (pro-clot) - degranulate alpha granules, activate GpIIb
- Cleavage of fibrinogen to fibrin (pro-clot)
- Activation of FXIII (for crosslinking of fibrin) (pro-clot)
- Amplification of its own production by activation of FXI, FV, and FVIII-vWF (pro-clot)
- Activation of FVII (pro-clot)
- Activation of TAFI (pro-clot)
- Activation of protein C (after binding to thrombomodulin) (anti-clot)
- Secretion of tPA from endothelium (anti-clot)
- Promotes binding of platelets to the endothelium (via PAR-1) (pro-clot)
- Also stimulates leukocytes to produce IL-1, IL-6, TNF-alpha through NF-kB pathway
What 2 complexes lead to the activation of FX
- FVIIa-TF
- FIXa-FVIIIa (tenase complex)
What is required for activation of plasminogen
- tPA (tissue-type plasminogen activator): Released under the action of thrombin, FXa, beta-adrenergic agents, histamine, bradykinin)
- Fibrin: lysine group binds on plasminogen and allows the activation by tPA
- uPA (urinary-type plasminogen activator): Can also activate plasminogen but only when cell-bound, does not require fibrin
What are endogenous inhibitors of fibrinolysis and their mechanisms of action
- Plasminogen activator inhibitor 1 (PAI-1): forms complexes with tPA and uPA
- Alpha-2 antiplasmin: binds to plasminogen and prevent its activation binding to fibrin OR cross-links fibrin which neutralizes the activity of plasmin
- Thrombin-activatable fibrinolysis inhibitor (TAFI): removes lysin residues from fibrin (once activated by thrombin-thrombomodulin complex and plasmin)
What proteins are responsible for termination of secondary hemostasis
- Tissue factor pathway inhibitor - secreted by endothelium
- Antithrombin (activated by heparin) - produced by liver
- Protein C (activated by thombin-thrombomodulin) and cofactor protein S - produced by liver (vitamin K dependent)
At which steps of the coagulation cascade is Ca2+ required
At each step involving factors II, VII, IX, X (vitamin-K dependent factors)